- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Sa | Vector Science and Therapeutics Corp: Vector Science grants option to buy 150,000 shares | 3 | Stockwatch | ||
| Sa | Vector Science and Therapeutics Corp.: Vector Science and Therapeutics Corp. Issues Options | 979 | Newsfile | Mequon, Wisconsin--(Newsfile Corp. - September 25, 2026) - Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced that the Board of Directors has approved the... ► Artikel lesen | |
| 26.08. | Vector Science and Therapeutics Corp. Enters Into an Investor Relations Agreement and Grants Options | 1 | CNW | ||
| 26.08. | Vector Science and Therapeutics Corp: Vector hires RedChip for investor relations services | 1 | Stockwatch | ||
| 24.08. | Vector Science & Therapeutics (TSXV: PAIN) Begins Peptide Production as First Suite at LyoGenesis Manufacturing Comes Online | 1 | CNW | ||
| 20.08. | Vector Science and Therapeutics Corp: Vector files patent for peptide orthopedic platform | 2 | Stockwatch | ||
| 20.08. | Vector Sciences & Therapeutics: Vector Science and Therapeutics Corp. (TSXV: PAIN) Files Provisional Patent Application on Integrated Platform for Orthopedic Tissue Regeneration Using Peptides | 234 | PR Newswire | Platform combines regenerative peptides with autologous platelet-rich biologics, alongside adjunct formulations designed to avoid interfering with the body's own... ► Artikel lesen | |
| 19.08. | Vector Science and Therapeutics Corp: Vector Science launches quality analytical testing | 1 | Stockwatch | ||
| VECTOR SCIENCE AND THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 17.08. | Vector Science and Therapeutics Corp: Vector, LyoGenesis amend licence, manufacturing deal | 1 | Stockwatch | ||
| 17.08. | Vector Sciences & Therapeutics: Vector Science and Therapeutics Corp. Signs Amended, 10-Year Manufacturing and Testing Agreement with LyoGenesis Holdings | 211 | PR Newswire | Long-term agreement secures U.S.-based, cGMP manufacturing capacity for Vector's proprietary peptide platform, with quality testing performed by its affiliate Verlytix
... ► Artikel lesen | |
| 29.07. | Vector Science and Therapeutics Corp: Vector Science related company signs MOU with Wynn | 5 | Stockwatch | ||
| 28.07. | Vector Sciences & Therapeutics: Vector Science & Therapeutics Corp., LyoGenesis Plus and Wynn Pharmaceuticals Announce Strategic Collaboration to Develop and Manufacture Critical Care Medical Products | 197 | PR Newswire | MEQUON, Wis. and LENEXA, Kan., July 28, 2026 /PRNewswire/ -- LyoGenesis Plus 1, LLC ("LyoGenesis Plus"), a company related to Vector Science & Therapeutics Corp.... ► Artikel lesen | |
| 25.07. | Vector Science and Therapeutics Corp: Vector files first financials since going public | 1 | Stockwatch | ||
| 25.07. | Vector Sciences & Therapeutics: Vector Science & Therapeutics Reports First Quarterly Financial Results as a Public Company; Announces Inaugural Investor Q&A on July 28 | 2.050 | PR Newswire | Peptide manufacturing vertical on track to begin generating revenue in August 2026; VectorMist 510(k) submission advancing toward FDA filing
MEQUON, Wis., July... ► Artikel lesen | |
| 22.07. | Vector Science and Therapeutics Corp: Vector Science to build distributor network | 1 | Stockwatch | ||
| 21.07. | Vector Science & Therapeutics Announces Distributor Network Buildout to Support Its Peptide Portfolio Across Orthopedic, Sports, and Regenerative Medicine Channels | 1 | CNW | ||
| 17.07. | Vector Science and Therapeutics Corp: Vector partners with Caresyntax on VectorMist data | 1 | Stockwatch | ||
| 17.07. | Vector Science & Therapeutics and Caresyntax Announce Real-World Evidence Partnership for VectorMist | 1 | CNW | ||
| 15.07. | Vector Science and Therapeutics Corp: Vector files 15 patent applications over two years | 1 | Stockwatch | ||
| 15.07. | Vector Science & Therapeutics Builds 15-Patent-Application Intellectual Property Portfolio Around Precision Therapeutic Delivery, Anchored by Peptide and Biologic Administration Technologies | 2 | CNW |
1 2 3 Weiter >>
47 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 38,940 | +1,56 % | Buy or Goodbye?: Meta, Novo Nordisk, SAP & Siemens Healthineers - Die Analystenstimmen des Tages | © Foto: Uwe Anspach/dpaMeta, Novo Nordisk, SAP, Siemens Healthineers: Die wichtigsten Analysten-Updates im Überblick Enthaltene Werte: DE0007164600,US30303M1027,DE000SHL1006,DK0062498333Den vollständigen... ► Artikel lesen | |
| FRESENIUS | 47,200 | +0,91 % | Fresenius baut Kapazität in Europa für 54 Mio Euro aus | DJ Fresenius baut Kapazität in Europa für 54 Mio Euro aus
DOW JONES--Fresenius hat seine Kapazitäten für die Herstellung von Infusionslösungen in Polen und Italien erweitert. Wie der DAX-Konzern... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,620 | +1,14 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| HEARTFLOW | 49,150 | -0,12 % | Canaccord raises HeartFlow stock price target on plaque analysis survey | ||
| CARL ZEISS MEDITEC | 31,260 | -1,52 % | 12 Prozent bessere Leistung, 14 Prozent weniger Belastung: Warum ZEISS das Brillenglas neu denkt - und wo Rise Nano Optics ins Spiel kommt | ||
| BILLIONTOONE | 121,80 | -1,18 % | Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently | ||
| GERRESHEIMER | 27,480 | -0,53 % | EQS-AFR: Gerresheimer AG: Vorabbekanntmachung über die Veröffentlichung von Quartalsberichten und Quartals-/Zwischenmitteilungen | EQS Vorabbekanntmachung Finanzberichte: Gerresheimer AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Gerresheimer AG: Vorabbekanntmachung über... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,06 | +0,79 % | Will M&A Be the Next Growth Factor as BTSG's Cash Flow and Leverage Improve? | ||
| ALIGNMENT HEALTHCARE | 8,050 | -2,01 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,605 | 0,00 % | Raymond James startet Coverage für Aveanna Healthcare mit "Strong Buy" | ||
| PROGYNY | 25,660 | +0,83 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| ECKERT & ZIEGLER | 12,605 | 0,00 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| GENEDX | 86,96 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| LIFESTANCE HEALTH GROUP | 11,950 | +0,97 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| MEDTRONIC | 77,38 | -0,51 % | Dividendenbekanntmachungen (25.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADF GROUP INC CA00089N1033 0,02 CAD 0,0124 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,22 USD 0,1933 EUR ASMODEE GROUP AB SE0023615638 - 0... ► Artikel lesen |
Das Unternehmen VECTOR SCIENCE AND THERAPEUTICS CORP kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VECTOR SCIENCE AND THERAPEUTICS CORP finden Sie auf Wallstreet Online.